News Releases

News Releases

Nov 18, 2019
NEW YORK --(BUSINESS WIRE)--Nov. 18, 2019-- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in uro-oncology, today announced that it will participate in fireside chats at the following conferences in November: Stifel 2019
Sep 30, 2019
  NEW YORK --(BUSINESS WIRE)--Sep. 30, 2019-- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in uro-oncology, today announced that it will present at the following conference in October:   2019 Cantor Global Healthcare